An International, Cross Sectional, Non-interventional, Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Ipsen57 sites in 7 countries340 target enrollmentOctober 2010

ConditionsNeuroendocrine Tumors Carcinoid Syndrome

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Neuroendocrine Tumors
Sponsor: Ipsen
Enrollment: 340
Locations: 57
Primary Endpoint: Subject's overall satisfaction regarding control of diarrhea
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of the protocol is to to assess subject's overall satisfaction regarding control of diarrhea. The study aims to supplement results obtained through clinical trials with data obtained from a population of patients receiving treatment with Somatuline Autogel in routine practice.

Registry

clinicaltrials.gov

Start Date

October 2010

End Date

December 2012

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Ipsen

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Out-patients 18 years of age and older, who have agreed to participate in the study
•Diagnosed with a Neuroendocrine tumour (NET) and receiving treatment with Somatuline Autogel

Exclusion Criteria

•Subjects for whom there are reasons that may hinder the conduct of the study (patients who have difficulty expressing themselves or who are unable to complete the questionnaires, or with insufficient data in the their files will not be enrolled in the study).